Labplus achieves success: 100% safety and high efficacy in the latest clinical study!

Kinga Chojnacka
Labplus achieves success: 100% safety and high efficacy in the latest clinical study!

Labplus celebrates triumph: our latest study confirms 100% safety and an impressive 40% drop in unnecessary doctor visits! This is a breakthrough for patient health!

At Labplus, we have a reason to be very happy! The results of our latest clinical study confirm that our vision of the gold standard in diagnostics and immediate medical information for patients is becoming a reality. This is a huge breakthrough for us!

The clinical study, considered the gold standard for evaluating the safety and efficacy of medical technologies, was carried out as part of a research grant from the National Center for Research and Development in cooperation with the largest and leading scientific institution – the Silesian Medical University in Katowice.

The study was led by Prof. Jerzy Chudek, MD, PhD, Head of the Department of Internal Medicine and Oncology Chemotherapy at the Silesian Medical University in Katowice, corresponding member of the Polish Academy of Sciences, who has interdisciplinary clinical experience as a specialist in internal medicine, nephrology, angiology, hypertension, clinical oncology and transplantation.

In the clinical study, which included 101 patients, we achieved a sensitivity of 100% in detecting life-threatening or health-threatening conditions, a sensitivity of 92.3% in identifying patients requiring urgent care, and an impressive accuracy of 74.3% – agreement of interpretation with the judgment of a medical specialist. Our technology proved to be extremely effective, eliminating unnecessary doctor visits by as much as 40%. Importantly, these are not just numbers on paper – they have a real impact on patients’ lives, by saving time, reducing stress and improving health.

The results of the study show that Labplus can safely and effectively help patients. We encourage you to read more about our study, available in the article at the provided link.

We would like to express our sincere gratitude to the extraordinary research team from the Silesian Medical University in Katowice, our Chief of Science, Bartłomiej Bartoszewicz, our Medical Director, Dr. Agnieszka Kuś, Dr. Leopold Rehan and the Medical Council and the entire Labplus team. We are very happy that together we can lead patients towards a better and healthier future!